NEW YORK, April 10, 2023 /PRNewswire/ — The herbal medicine market size is forecasted to increase by USD 36,636.05 million from 2022 to 2027, at a CAGR of 5.96%, according to the recent market study by Technavio. The growth of the market will be driven by the immunity-boosting properties of herbal medicines, low side effects, and natural healing by using herbal remedies. Charts & data tables about market and segment sizes for a historic period (2017-2021) and forecast period (2023-2027) have been covered in this report. Download the Sample Report
Vendor Analysis
The herbal medicine market report includes information on the key products and recent developments of leading vendors, including:
-
Arkopharma Laboratories: The company offers herbal medicines such as Arkofluides Articulations BIO.
-
Beijing Tongrentang Co Ltd.: The company offers herbal medicines such as Angong Niuhuang Wan.
-
Bio Botanica Inc.: The company offers herbal medicines such as organic wild cherry bark in glycerin.
-
Blackmores Ltd.: The company offers herbal medicines such as milk thistle and tranquil night.
-
Charak Pharma Pvt. Ltd.
-
Dabur India Ltd.
-
Dasherb Corp.
-
Dr. Willmar Schwabe GmbH and Co. KG
-
Emami Ltd.
-
Hamdard Laboratories
-
Himalaya Global Holdings Ltd.
-
Hishimo Pharmaceuticals Pvt. Ltd.
-
Imperial Ginseng Products Ltd.
-
Ricola Group AG
-
Schaper and Brummer GmbH and Co. KG
Why Buy?
-
Add credibility to strategy
-
Analyzes competitor’s offerings
-
Get a holistic view of the market
Grow your profit margin with Technavio – Buy the Report
Key Benefits for Industry Players & Stakeholders –
-
The report offers information on the criticality of vendor inputs, including R&D, CAPEX, and technology.
-
It also provides detailed analyses of the market’s competitive landscape and vendors’ product offerings.
-
The report also provides a qualitative and quantitative analysis of vendors to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
Get a holistic overview of the market by industry experts to evaluate and develop growth strategies. Download the Sample
Market Segmentation:
The market is segmented by product (capsules and tablets, powders, extracts, syrups, and others), distribution channel (hospitals, retail pharmacies, and e-commerce), and geography (Asia, North America, Europe, and the Rest of the World (ROW))
By product, the market growth will be significant in the capsules and tablets segment during the forecast period. In this segment, tablets are inexpensive, safe, and effective oral medications. Caplets, which are elongated tablets, may be easier to swallow. Some have a notch in the middle to make it easier to separate the two halves of the tablet. The capsule shell breaks down in the gastrointestinal tract, and the active pharmaceutical ingredients are absorbed into the body, distributed, and processed in a manner similar to tablets taken. The above factors drive the growth of